Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Eleanor Roosevelt's cause of death and end of life issues examined during clinicopathological conference

Eleanor Roosevelt's cause of death and end of life issues examined during clinicopathological conference

Obese teens are likely to suffer nutritional deficiencies, says study

Obese teens are likely to suffer nutritional deficiencies, says study

RDT receives FDA approval for new liquid form of treatment for patients with ALL

RDT receives FDA approval for new liquid form of treatment for patients with ALL

Study: Mutations could have major impact on treatment of human blood diseases

Study: Mutations could have major impact on treatment of human blood diseases

Oral health: The gateway to your overall health

Oral health: The gateway to your overall health

Alexion Pharmaceuticals obtains orphan drug designation from EC for Soliris

Alexion Pharmaceuticals obtains orphan drug designation from EC for Soliris

Agios begins AG-348 Phase 1 study to treat PK deficiency

Agios begins AG-348 Phase 1 study to treat PK deficiency

Baxter reports topline results from BAX 111 Phase 3 trial for treatment of von Willebrand disease

Baxter reports topline results from BAX 111 Phase 3 trial for treatment of von Willebrand disease

Akebia completes enrollment in ongoing 200-patient Phase 2b study of AKB-6548

Akebia completes enrollment in ongoing 200-patient Phase 2b study of AKB-6548

New drug combination proves effective in treating patients with HCV genotype 1

New drug combination proves effective in treating patients with HCV genotype 1

Doc receives grant for helping young adults to move from child-centered to adult-oriented health care system

Doc receives grant for helping young adults to move from child-centered to adult-oriented health care system

Scientists design new system for molecular blood group typing

Scientists design new system for molecular blood group typing

Janssen submits supplemental New Drug Application for IMBRUVICA to the U.S. FDA

Janssen submits supplemental New Drug Application for IMBRUVICA to the U.S. FDA

Gilead reports topline results from sofosbuvir Phase 3 trial in Japan for treatment of HCV infection

Gilead reports topline results from sofosbuvir Phase 3 trial in Japan for treatment of HCV infection

Discovery could lead to new therapies for people with celiac disease

Discovery could lead to new therapies for people with celiac disease

Otsuka inks agreement with Eisai to acquire rights to hematological cancer treatment Dacogen

Otsuka inks agreement with Eisai to acquire rights to hematological cancer treatment Dacogen

Physicians suspect that chemotherapy can accelerate aging process

Physicians suspect that chemotherapy can accelerate aging process

EORTC study does not support combination chemotherapy for soft tissue sarcoma

EORTC study does not support combination chemotherapy for soft tissue sarcoma

Imaging cancer in children using MRI: an interview with Dr. Heike E. Daldrup-Link, Stanford University School of Medicine

Imaging cancer in children using MRI: an interview with Dr. Heike E. Daldrup-Link, Stanford University School of Medicine

Emmaus reports preliminary top-line results from Phase 3 clinical trial for treatment of sickle cell disease

Emmaus reports preliminary top-line results from Phase 3 clinical trial for treatment of sickle cell disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.